Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
John Chia(National Cancer Centre Singapore), Han Chong Toh(National Cancer Centre Singapore), Gwo Fuang Ho(University of Malaya), Raghib Ali(University of Oxford), Peter M. Rothwell(UK Dementia Research Institute), Joong Bae Ahn(Yonsei University), Fiona Day(Calvary Mater Newcastle Hospital), Robert Zielinski, Tom van Hagen(St John of God Subiaco Hospital), Shuting Han(Zhejiang University), Estelle Mei Jye Foo(National Cancer Centre Singapore), Chen Gong(Fudan University), Nabilah Rahman(National University Health System), Theresa Hayes(St John of God Hospital), Eva Segelov(University of Bern), Chee Kian Tham(National Cancer Centre Singapore), Kefeng Ding(Second Affiliated Hospital of Zhejiang University), Mihir Gandhi(Duke-NUS Medical School), Thomas Yau(University of Hong Kong), Wei Wang(Capital Medical University), Yong Li(Guangdong Academy of Medical Sciences), Atul Sharma(All India Institute of Medical Sciences), Shaesta Mehta(Tata Memorial Hospital), John Simes(The University of Sydney), Tsu-Yi Chao(Ministry of Health and Welfare), Louise Nott, Mark Jeffery(Christchurch Hospital), Po‐Li Wei(Taipei Medical University Hospital), Jiewen Peng(Zhongshan People's Hospital), Yanhong Deng(Sun Yat-sen University)
Cited by 34